|The C5AR2 c5ar2 (Catalog #MBS602223) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Complement C3a, C3a des-Arg, Human reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s Complement C3a, C3a des-Arg can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 1:16,000. Researchers should empirically determine the suitability of the C5AR2 c5ar2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The C5AR2 c5ar2 product has the following accession number(s) (GI #415712997) (NCBI Accession #NP_001258679.1) (Uniprot Accession #Q9P296). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Complement C3a is an anaphylatoxin of 77 amino acid residues released by the action of the C3 convertases on the N-terminal of the alpha chain of C3. It is rapidly inactivated by serum carboxypeptidase N which removes the C-terminal arginine residue generating C3a (desArg).
Immunogen: Human C3a. Hybridoma: Balb/c mice. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing C5AR2 are readily searchable from our website. Different antibodies against the same target such as C5AR2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene.